AI models need more data about biology, and OpenAI is paying to create it
Biotechnology and healthAI models need more data about biology, and OpenAI is paying to create itThe OpenAI Foundation is funding a new effort called Data for Public Health. By Antonio Regaladoarchive pageSeptember 15, 2026Stephanie Arnett/MIT Technology Review | Adobe Stock Last year Ruxandra Teslo, a policy analyst who focuses on clinical trials, posted an idea for supercharging medical AI systems: Use data from failed biotech companies. By bidding at their bankruptcy proceedings, she proposed, it might be possible to obtain detailed regulatory filings, manufacturing strategies, and safety data—types of information usually considered trade secrets.
- ▪Biotechnology and healthAI models need more data about biology, and OpenAI is paying to create itThe OpenAI Foundation is funding a new effort called Data for Public Health.
- ▪By Antonio Regaladoarchive pageSeptember 15, 2026Stephanie Arnett/MIT Technology Review | Adobe Stock Last year Ruxandra Teslo, a policy analyst who focuses on clinical trials, posted an idea for supercharging medical AI systems: Use data f
- ▪By bidding at their bankruptcy proceedings, she proposed, it might be possible to obtain detailed regulatory filings, manufacturing strategies, and safety data—types of information usually considered trade secrets.
2 outlets in our directory ran this story, first to last over 23 hours. All of the coverage we found sits in one bucket: centre. That one-sidedness is itself worth noticing.
Hacker News (AI / LLM) files mainly under ai. We currently carry 5,139 of its stories.
Story provenance
Source · retrieval · rights · ranking — open for full record
inspect →
Story provenance
Attribution is not the same as permission. This drawer separates discovery metadata, excerpts, WeSearch-generated summaries, reuse status, and whether the publisher receives the visit. Nothing here claims a legal grant the publisher has not made.
Record
| Original publisher | MIT Technology Review |
| Canonical URL | https://www.technologyreview.com/2026/09/15/1144129/ai-models-need-more-data-about-biology-and-openai-is-paying-to-create-it/ |
| Publication time | Wed, 16 Sep 2026 11:02:27 +0000 |
| Retrieval time | 2026-09-16T11:03:41.632Z |
| Last seen | 2026-09-16T11:03:41.632Z |
| Headline source | Publisher (no WeSearch rewrite) |
| Excerpt source | publisher body |
| Excerpt method | First ~120 words (~800 chars) of extracted publisher body, fair-use limited. |
| Summary | WeSearch · cerebras-chat (WeSearch summarizer) |
| Summary source text | contentText |
| Citation coverage | Summary is a WeSearch-generated derivative; primary citation is the original publisher URL. |
| Cluster | Fa8wdAsBfrrX · 2 stories |
| Cluster logic | Grouped by semantic title/content similarity across sources within a rolling window. Same-publisher template collisions are excluded from coverage comparison. |
| Ranking reason | Story pages are not engagement-ranked. Hub feeds use recency, with optional source-diversified chronological ordering (cap consecutive stories per source). No personalized ranking. |
| Publisher visit | Yes — open original |
| Substitutes article? | No — link-out required for full text |
Rights status (four layers)
WeSearch handling by dimension
| Indexing | May the item be indexed (stored, ranked, made findable)? | Allowed |
| Snippet | May a short excerpt of the publisher's text be shown? | Allowed |
| AI summary | May WeSearch generate its own short summary of the article? | Limited |
| Retrieval / RAG | May the content be exposed for third-party retrieval-augmented generation? | Not asserted |
| Model training | May the content be used to train AI models? | Not asserted |
| Commercial reuse | May the content be reused commercially? | Not permitted |
Basis: Derived from the published RSS/Atom feed. Contact: [email protected]. Reviewed: 2026-07-24.
Opening excerpt (first ~120 words) tap to expand
Biotechnology and healthAI models need more data about biology, and OpenAI is paying to create itThe OpenAI Foundation is funding a new effort called Data for Public Health. By Antonio Regaladoarchive pageSeptember 15, 2026Stephanie Arnett/MIT Technology Review | Adobe Stock Last year Ruxandra Teslo, a policy analyst who focuses on clinical trials, posted an idea for supercharging medical AI systems: Use data from failed biotech companies. By bidding at their bankruptcy proceedings, she proposed, it might be possible to obtain detailed regulatory filings, manufacturing strategies, and safety data—types of information usually considered trade secrets.
…
Excerpt limited to ~120 words for fair-use compliance. The full article is at MIT Technology Review.
Discussion
0 commentsMore from MIT Technology Review
